TNFα genotype influences development of IgA-ASCA antibodies in Crohn's disease patients with CARD15 wild type

被引:7
作者
Castro-Santos, Patricia
Mozo, Lourdes
Gutierrez, Carmen
Suarez, Ana
机构
[1] Univ Oviedo, Dept Funct Biol, Immunol Area, E-33006 Oviedo, Spain
[2] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain
关键词
inflammatory bowel disease; CD; cytokine polymorphisms; ASCA; PAB; TNF alpha; IL-10; CARD15;
D O I
10.1016/j.clim.2006.07.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A typical feature of Crohn's disease (CD) patients is the development of antibodies against self - (PAB) or exogenous (ASCA) antigens, a process in which mucosal cytokine expression pattern might be involved. On the other hand, mutations in CARD15, a genetic risk factor for CD, alter cytokine production in response to bacterial. infection. In the present study, we evaluated the rote of functionally relevant IL-10 and TNF alpha gene polymorphisms in the synthesis of these antibodies and their relationship with CARD15 mutations. In CARD15 wild type patients, high TNFa producer genotypes protect against IgA-ASCA development, whereas an inverse association was observed in autoantibody synthesis (PAB). These associations were not observed in patients with CARD15 mutations, probably due to the Lack of TNF alpha release as a consequence of the failure of CARD15 protein to recognize the peptidoglycan. Thus, we proposed a CARD15-TNF alpha circuit that might play a role in mucosal immune surveillance. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 55 条
[1]   Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease [J].
Abreu, MT ;
Taylor, KD ;
Lin, YC ;
Hang, T ;
Gaiennie, J ;
Landers, CJ ;
Vasiliauskas, EA ;
Kam, LY ;
Rojany, M ;
Papadakis, KA ;
Rotter, JI ;
Targan, SR ;
Yang, HY .
GASTROENTEROLOGY, 2002, 123 (03) :679-688
[2]   The molecular classification of the clinical manifestations of Crohn's disease [J].
Ahmad, T ;
Armuzzi, A ;
Bunce, M ;
Mulcahy-Hawes, K ;
Marshall, SE ;
Orchard, TR ;
Crawshaw, J ;
Large, O ;
De Silva, A ;
Cook, JT ;
Barnardo, M ;
Cullen, S ;
Welsh, KI ;
Jewell, DP .
GASTROENTEROLOGY, 2002, 122 (04) :854-866
[3]   Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis:: A GISC study [J].
Annese, V ;
Andreoli, A ;
Andriulli, A ;
D'Inca, R ;
Gionchetti, P ;
Latiano, A ;
Lombardi, G ;
Piepoli, A ;
Poulain, D ;
Sendid, B ;
Colombel, JF .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (08) :2407-2412
[4]   Variants of CARD 15 are associated with an aggressive clinical course of Crohn's disease -: An IG-IBD study [J].
Annese, V ;
Lombardi, G ;
Perri, F ;
D'Incá, R ;
Ardizzone, S ;
Riegler, G ;
Giaccari, S ;
Vecchi, M ;
Castiglione, F ;
Gionchetti, P ;
Cocchiara, E ;
Vigneri, S ;
Latiano, A ;
Palmieri, O ;
Andriulli, A .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (01) :84-92
[5]   Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype [J].
Arnott, IDR ;
Landers, CJ ;
Nimmo, EJ ;
Drummond, HE ;
Smith, BKR ;
Targan, SR ;
Satsangi, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2376-2384
[6]   Identification and characterization of a novel regulatory factor: IgA-inducing protein [J].
Austin, AS ;
Haas, KM ;
Naugler, SM ;
Bajer, AA ;
Garcia-Tapia, D ;
Estes, DM .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1336-1342
[7]   Investigation of the prognostic value of TNF-α gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-α production and apoptosis [J].
Balog, A ;
Klausz, G ;
Gál, J ;
Molnár, T ;
Nagy, F ;
Ocsovszky, I ;
Gyulai, Z ;
Mándi, Y .
PATHOBIOLOGY, 2004, 71 (05) :274-280
[8]   SERUM ANTIBODIES REACTIVE WITH SACCHAROMYCES-CEREVISIAE IN INFLAMMATORY BOWEL-DISEASE - IS IGA ANTIBODY A MARKER FOR CROHNS-DISEASE [J].
BARNES, RMR ;
ALLAN, S ;
TAYLORROBINSON, CH ;
FINN, R ;
JOHNSON, PM .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1990, 92 (01) :9-15
[9]   Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan [J].
Bonen, DK ;
Ogura, Y ;
Nicolae, DL ;
Inohara, N ;
Saab, L ;
Tanabe, T ;
Chen, FF ;
Foster, SJ ;
Duerr, RH ;
Brant, SR ;
Cho, JH ;
Nuñez, G .
GASTROENTEROLOGY, 2003, 124 (01) :140-146
[10]   Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes [J].
Brant, SR ;
Picco, MF ;
Achkar, JP ;
Bayless, TM ;
Kane, SV ;
Brzezinski, A ;
Nouvet, FJ ;
Bonen, D ;
Karban, A ;
Dassopoulos, T ;
Karaliukas, R ;
Beaty, TH ;
Hanauer, SB ;
Duerr, RH ;
Cho, JH .
INFLAMMATORY BOWEL DISEASES, 2003, 9 (05) :281-289